Literature DB >> 33255089

Recent advances in the redox-responsive drug delivery nanoplatforms: A chemical structure and physical property perspective.

Shirin Mollazadeh1, Marcin Mackiewicz2, Mostafa Yazdimamaghani3.   

Abstract

Poor water solubility, off-target toxicity, and small therapeutic window are among major obstacles for the development of drug products. Redox-responsive drug delivery nanoplatforms not only overcome the delivery and pharmacokinetic pitfalls observed in conventional drug delivery, but also leverage the site-specific delivery properties. Cleavable diselenide and disulfide bonds in the presence of elevated reactive oxygen species (ROS) and glutathione concentration are among widely used stimuli-responsive bonds to design nanocarriers. This review covers a wide range of redox-responsive chemical structures and their properties for designing nanoparticles aiming controlled loading, delivery, and release of hydrophobic anticancer drugs at tumor site.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cleavable linkers; Drug delivery; Nanomedicine; Nanoparticle; Redox-responsive

Mesh:

Substances:

Year:  2020        PMID: 33255089     DOI: 10.1016/j.msec.2020.111536

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  14 in total

Review 1.  Redox-Responsive Mesoporous Silica Nanoparticles for Cancer Treatment: Recent Updates.

Authors:  Miguel Gisbert-Garzarán; María Vallet-Regí
Journal:  Nanomaterials (Basel)       Date:  2021-08-28       Impact factor: 5.719

Review 2.  Smart Nanomaterials for Biomedical Applications-A Review.

Authors:  Magdalena Aflori
Journal:  Nanomaterials (Basel)       Date:  2021-02-04       Impact factor: 5.076

Review 3.  Current Methods in the Study of Nanomaterials for Bone Regeneration.

Authors:  Manabu Tanaka; Makoto Izumiya; Hisao Haniu; Katsuya Ueda; Chuang Ma; Koki Ueshiba; Hirokazu Ideta; Atsushi Sobajima; Shigeharu Uchiyama; Jun Takahashi; Naoto Saito
Journal:  Nanomaterials (Basel)       Date:  2022-04-02       Impact factor: 5.076

4.  Dual Responsive poly(vinyl caprolactam)-Based Nanogels for Tunable Intracellular Doxorubicin Delivery in Cancer Cells.

Authors:  Kummara Madhusudana Rao; Maduru Suneetha; Dachuru Vinay Kumar; Hyeon Jin Kim; Yong Joo Seok; Sung Soo Han
Journal:  Pharmaceutics       Date:  2022-04-13       Impact factor: 6.525

5.  The development of a redox-sensitive curcumin conjugated chitosan oligosaccharide nanocarrier for the efficient delivery of docetaxel to glioma cells.

Authors:  Chunxi Liu; Yuan Gao; Lixia Zhao; Rui Wang; Fei Xie; Guangxi Zhai; Anchang Liu
Journal:  Ann Transl Med       Date:  2022-03

6.  Oxidation and Reduction Dual-Responsive Polymeric Prodrug Micelles Co-delivery Precisely Prescribed Paclitaxel and Honokiol for Laryngeal Carcinoma Combination Therapy.

Authors:  Lanzhu Zhou; Jun Wu; Zhe Sun; Wenzhong Wang
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

Review 7.  Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency.

Authors:  Zhilin Li; Xiaoqin Lai; Shiqin Fu; Long Ren; Hao Cai; Hu Zhang; Zhongwei Gu; Xuelei Ma; Kui Luo
Journal:  Adv Sci (Weinh)       Date:  2022-06-02       Impact factor: 17.521

8.  Enzyme-triggered- and tumor-targeted delivery with tunable, methacrylated poly(ethylene glycols) and hyaluronic acid hybrid nanogels.

Authors:  Wioletta Liwinska; Ewelina Waleka-Bagiel; Zbigniew Stojek; Marcin Karbarz; Ewelina Zabost
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 9.  Silica-Based Stimuli-Responsive Systems for Antitumor Drug Delivery and Controlled Release.

Authors:  Avelino Corma; Pablo Botella; Eva Rivero-Buceta
Journal:  Pharmaceutics       Date:  2022-01-04       Impact factor: 6.321

Review 10.  Heterocycle/Heteroallene Ring-Opening Copolymerization: Selective Catalysis Delivering Alternating Copolymers.

Authors:  Alex J Plajer; Charlotte K Williams
Journal:  Angew Chem Int Ed Engl       Date:  2021-10-19       Impact factor: 16.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.